Importantly, GA-NPs@DCV exerts potent anti-ovarian cancer effects by promoting immune activation, inhibiting immune evasion through the Stat3/IDO1/AhR signaling axis, and remodeling tumor immune microenvironment <i>via</i> regulation of the tryptophan metabolic pathway. This evidence concerns the gene AHR and ovarian cancer.